Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed or Refractory EBV-and CD30-positive Lymphomas

Clinical trial condition

Relapsed or Refractory EBV-and CD30-positive Lymphomas

Explore clinical trials studying Relapsed or Refractory EBV-and CD30-positive Lymphomas. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Relapsed or Refractory EBV-and CD30-positive Lymphomas trial results

Completed

Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas

NCT02388490

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Seoul National University Bundang Hospital Seongnam, South Korea

Seoul National Unversity Hospital Seoul, South Korea

SMG-SNU Boramae Medical Center Seoul, South Korea

View Trial Details